Developer docs
API playgroundTry for free, no card

Search company profiles

Venn Life Sciences

Full company profile

uuid0006r9h

Namestring
Venn Life Sciences
Legal namestring
hVIVO Services Limited
Company typeenum
Public
Founded yearint
1989
Descriptiontext

Venn Life Sciences is a contract research organization (CRO) that delivers clinical trial services spanning pre-clinical through Phase III, with a particular concentration in early-phase and human challenge trial work. The company has been consolidated, alongside hVIVO, Cryostore, and CRS, under the unified 'One hVIVO' brand, operating as a wholly-owned subsidiary of the AIM-listed hVIVO group. Venn Life Sciences brings historical drug development consulting, clinical operations, and biostatistics capability to the platform, complemented by the group's purpose-built UK and German clinical research facilities, CL3 laboratories, HTA-licensed cryostorage and biobanking, and world-leading human challenge trial models covering RSV, Influenza, COVID-19, HRV, hMPV, Malaria, and Asthma & COPD. The combined entity positions itself as an integrated early-phase drug development platform with capabilities across consultancy, clinical delivery, laboratory services, recruitment, and storage.

Revenue is generated primarily through project-based, professional services contracts negotiated per study scope, phase, therapeutic area, and complexity, with multi-year contract cadences. The customer base is segmented vertically across global pharma, biotech, CROs, start-ups, and drug development investors, served through a direct enterprise field sales motion with no resellers or distributors. The go-to-market leverages thought leadership via scientific publications, webinars, industry conferences (BIO International, World Vaccine Congress Europe, BIO-Europe), and small expert-led workshops targeted at technical due diligence and target product profile discussions.

Venn Life Sciences itself has a track record of inorganic growth, completing five acquisitions between 2010 and 2015 (DCI France, CRM Clinical Trials, medevol, Cardinal Systems SAS, Kinesis Pharma B.V.) before being integrated into the One hVIVO platform. The group continues to invest in capacity, including a new Canary Wharf headquarters facility opened in June 2024, the January 2025 acquisition of German CRO CRS, and the first-in-Europe deployment of Bio-Rad's Droplet Digital PCR technology. The firm operates with 51-100 employees and trades on the London Stock Exchange.

Short descriptiontext

Venn Life Sciences is a CRO delivering pre-clinical through Phase III clinical trial services, now operating as a subsidiary within the AIM-listed One hVIVO group, which specializes in human challenge trials, integrated clinical operations, bioanalysis, and cryobiobanking for global pharma, biotech, and investors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWhitechapel, United Kingdom
HQ citystring
Whitechapel
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, drug development consulting, contract research organization, human challenge trials, bioanalytical laboratory services
Industry6 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Contract Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Clinical Trial Services
TypeProfessional Services
Description

Full-service CRO offering end-to-end clinical trial delivery across Phase I-III. Revenue generated through project-based contracts for clinical trial management, with services including medical monitoring, data management, project management, and quality assurance.

hvivo.com
2Drug Development Consulting
TypeProfessional Services
Description

Strategic and scientific consultancy services including regulatory affairs, CMC consulting, due diligence, and medical writing. Provides investor readiness consulting for biotech clients.

hvivo.com
3Laboratory Services
TypeProfessional Services
Description

Comprehensive laboratory services including bioanalysis, virology, immunology, biomarker analysis, and PBMC processing. Integrated with clinical operations for consistent data generation.

hvivo.com
4Human Challenge Trials
TypeProfessional Services
Description

Specialist challenge trial services generating early efficacy data for vaccines and therapeutics. Includes virus production, characterization, and clinical delivery.

hvivo.com
5Biobank and Storage Solutions
TypeManaged Services
Description

Cryostorage and biobanking services for biological samples and clinical materials with HTA licensing.

hvivo.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Project-based CRO services with custom scope
ModelOtherBilling cadenceMulti-year contract
Notes

Contracts typically negotiated based on study requirements, therapeutic area, phase, and complexity. No standard pricing tiers publicly available.

hvivo.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Venn Life Sciences provides contract clinical research services from pre-clinical through Phase III, delivering full-service CRO capabilities including clinical trial management, regulatory affairs, biostatistics, medical monitoring, and data management. The company also offers drug development consulting (CMC, regulatory, non-clinical, due diligence, PK/PD), specialized human challenge trials for infectious disease, bioanalytical and virology laboratory services, and HTA-licensed cryostorage and biobanking. Services are delivered to pharmaceutical, biotechnology, and CRO customers across the UK and Germany under the integrated One hVIVO brand.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 1,900+ trials completed successfully
+2 more records
Product and service6 records
1Clinical Trial Solutions
CategoryClinical Trial Services
Description

Comprehensive Phase I–III clinical trial delivery including medical monitoring, data management, project management, biostatistics, quality assurance, medical writing, regulatory affairs, clinical trial sites, recruitment, and clinical PK/PD services for pharma and biotech sponsors.

2Drug Development Consulting
CategoryConsulting Services
Description

Strategic and scientific consultancy covering regulatory affairs, CMC consulting, non-clinical development, due diligence, biosample project management, statistics and study design, clinical PK/PD and translational modelling, medical writing, and clinical trials legal services for drug development sponsors and investors.

3Human Challenge Trials
CategoryClinical Trial Services
Description

Specialist controlled-pathogen challenge trials in dedicated quarantine facilities using proprietary models for RSV, Influenza, COVID-19, HRV, hMPV, Malaria, and Asthma & COPD, including virus production and characterization, participant screening and recruitment, and clinical delivery to generate early efficacy data.

4Laboratory Solutions
CategoryLaboratory Services
Description

Advanced laboratory services across bioanalysis and characterization, virology, immunology, molecular biology, microbiology, PBMC processing, assay development and validation, preclinical PK/PD studies, and Bio-Rad Droplet Digital PCR for clinical trial sponsors.

5Biobank and Storage Solutions
CategoryStorage and Biobanking Services
Description

HTA-licensed cryostorage and biobanking services with multi-temperature storage, 24/7 monitoring, full chain-of-custody management, and fast local access for biotech, pharma, and research partners' biological samples and clinical materials.

6Integrated Solutions
CategoryIntegrated Drug Development Services
Description

End-to-end integrated drug development platform combining clinical, laboratory, recruitment, and consultancy expertise, including the Speed to Clinic Accelerator, Investor Readiness Consulting, Integrated Clinical Trial Delivery, Translational Research Consulting, and EU Expansion Strategy for sponsors.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

German clinical research company acquired by hVIVO in January 2025. CRS operates clinical research facilities in Germany and is now integrated under the unified One hVIVO brand, extending capabilities in early-phase clinical trials and recruitment.

2Cryostore
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Specialist cryostorage and biobanking company acquired by hVIVO. Provides HTA-licensed cryostorage and biobanking services with multi-temperature storage, 24/7 monitoring, and full chain-of-custody management. Now part of the integrated One hVIVO brand.

manufacturing-today.com
Strategic tierCoreTypeTechnology or Integration
Description

hVIVO became the first in Europe to deploy Bio-Rads Droplet Digital PCR technology, enhancing bioanalysis and characterization capabilities for clinical trials and laboratory services.

4Venn Life Sciences
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Acquired company now operating under the unified One hVIVO brand. Part of the strategic integration bringing together hVIVO, Cryostore, CRS, and Venn Life Sciences to offer fully integrated early-phase drug development solutions.

hvivo.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Integrated CRO/CDMO offering lab services, preclinical research, clinical trial support and drug development consulting. Comparable to hVIVO's integrated early-phase platform with comparable sponsor base and similar emphasis on accelerating biotech drug development.

TypeBroad incumbent
Description

One of the world's largest clinical CROs offering Phase I-IV trial delivery, lab services and consulting. Significantly larger and more diversified than hVIVO, but directly competes for the same global pharma and biotech sponsors seeking integrated early-phase and Phase II/III delivery.

TypeBroad incumbent
Description

Global mega-CRO with clinical operations, real-world data, laboratory and consulting services. Comparable to hVIVO in serving pharma/biotech sponsors with integrated drug development solutions, but at vastly greater scale and geographic reach.

TypeBroad incumbent
Description

Preclinical and clinical CRO with strong biologics and laboratory services franchises. Comparable to hVIVO in combining preclinical/early-phase research capabilities with safety and bioanalytical lab services for pharma and biotech sponsors.

TypeBroad incumbent
Description

Global full-service CRO with Phase I-IV capabilities, biostatistics, regulatory affairs and bioanalytical services. Competes with hVIVO for pharma and biotech early-phase contracts but with materially greater global infrastructure.

TypeDirect peer
Description

Mid-sized global CRO focused on Phase I-IV clinical development with strong medical, regulatory and biostatistics expertise. Closely comparable operating model to hVIVO in serving small-to-mid biotech with full-service early-phase trials, though without the specialized human challenge franchise.

TypeDirect peer
Description

Mid-sized global CRO with Phase I-IV capabilities across complex therapeutic areas. Comparable in size and sponsor mix to hVIVO, particularly for biotech and specialty pharma early-phase work.

TypeBroad incumbent
Description

Global biopharma solutions organization combining clinical CRO services with commercial capabilities. Competes with hVIVO for full-service Phase I-III trials and consultancy work from pharma and biotech sponsors.

TypeBroad incumbent
Description

Diversified testing, inspection and certification company with a life sciences/CRO division including early-phase clinical and bioanalytical services. Comparable to hVIVO's lab and clinical research capabilities, particularly in infectious disease and vaccine studies, though SGS operates across many non-pharma verticals.

TypeBroad incumbent
Description

Global laboratory services group with a significant clinical trial laboratory and central lab business. Comparable to hVIVO in providing bioanalytical, virology, immunology and biomarker lab services to pharma and biotech sponsors, though without equivalent clinical operations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Venn Life Sciences

Contract Research Organization (CRO) Servicesvennlifesciences.com

Venn Life Sciences is a CRO delivering pre-clinical through Phase III clinical trial services, now operating as a subsidiary within the AIM-listed One hVIVO group, which specializes in human challenge trials, integrated clinical operations, bioanalysis, and cryobiobanking for global pharma, biotech, and investors.

What Venn Life Sciences does

Venn Life Sciences is a contract research organization (CRO) that delivers clinical trial services spanning pre-clinical through Phase III, with a particular concentration in early-phase and human challenge trial work. The company has been consolidated, alongside hVIVO, Cryostore, and CRS, under the unified 'One hVIVO' brand, operating as a wholly-owned subsidiary of the AIM-listed hVIVO group. Venn Life Sciences brings historical drug development consulting, clinical operations, and biostatistics capability to the platform, complemented by the group's purpose-built UK and German clinical research facilities, CL3 laboratories, HTA-licensed cryostorage and biobanking, and world-leading human challenge trial models covering RSV, Influenza, COVID-19, HRV, hMPV, Malaria, and Asthma & COPD. The combined entity positions itself as an integrated early-phase drug development platform with capabilities across consultancy, clinical delivery, laboratory services, recruitment, and storage.

Revenue is generated primarily through project-based, professional services contracts negotiated per study scope, phase, therapeutic area, and complexity, with multi-year contract cadences. The customer base is segmented vertically across global pharma, biotech, CROs, start-ups, and drug development investors, served through a direct enterprise field sales motion with no resellers or distributors. The go-to-market leverages thought leadership via scientific publications, webinars, industry conferences (BIO International, World Vaccine Congress Europe, BIO-Europe), and small expert-led workshops targeted at technical due diligence and target product profile discussions.

Venn Life Sciences itself has a track record of inorganic growth, completing five acquisitions between 2010 and 2015 (DCI France, CRM Clinical Trials, medevol, Cardinal Systems SAS, Kinesis Pharma B.V.) before being integrated into the One hVIVO platform. The group continues to invest in capacity, including a new Canary Wharf headquarters facility opened in June 2024, the January 2025 acquisition of German CRO CRS, and the first-in-Europe deployment of Bio-Rad's Droplet Digital PCR technology. The firm operates with 51-100 employees and trades on the London Stock Exchange.

Venn Life Sciences firmographics

Firmographics
Name
Venn Life Sciences
Legal name
hVIVO Services Limited
Website
https://vennlifesciences.com
Company type
Public
Founded year
1989
Operating status
Operating
Headcount range
51–100 employees
Short description
Venn Life Sciences is a CRO delivering pre-clinical through Phase III clinical trial services, now operating as a subsidiary within the AIM-listed One hVIVO group, which specializes in human challenge trials, integrated clinical operations, bioanalysis, and cryobiobanking for global pharma, biotech, and investors.
Ownership category
akta.pro rank

Venn Life Sciences industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Clinical trial services
  • Drug development consulting
  • Contract research organization
  • Human challenge trials
  • Bioanalytical laboratory services

Where Venn Life Sciences is headquartered

Location

Headquarters

HQ city
Whitechapel
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Venn Life Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Trial Services: Full-service CRO offering end-to-end clinical trial delivery across Phase I-III. Revenue generated through project-based contracts for clinical trial management, with services including medical monitoring, data management, project management, and quality assurance.
  2. Drug Development Consulting: Strategic and scientific consultancy services including regulatory affairs, CMC consulting, due diligence, and medical writing. Provides investor readiness consulting for biotech clients.
  3. Laboratory Services: Comprehensive laboratory services including bioanalysis, virology, immunology, biomarker analysis, and PBMC processing. Integrated with clinical operations for consistent data generation.
  4. Human Challenge Trials: Specialist challenge trial services generating early efficacy data for vaccines and therapeutics. Includes virus production, characterization, and clinical delivery.
  5. Biobank and Storage Solutions: Cryostorage and biobanking services for biological samples and clinical materials with HTA licensing.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based CRO services with custom scope

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Venn Life Sciences product offering

Product offering

Core offering

Venn Life Sciences provides contract clinical research services from pre-clinical through Phase III, delivering full-service CRO capabilities including clinical trial management, regulatory affairs, biostatistics, medical monitoring, and data management. The company also offers drug development consulting (CMC, regulatory, non-clinical, due diligence, PK/PD), specialized human challenge trials for infectious disease, bioanalytical and virology laboratory services, and HTA-licensed cryostorage and biobanking. Services are delivered to pharmaceutical, biotechnology, and CRO customers across the UK and Germany under the integrated One hVIVO brand.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Solutions Comprehensive Phase I–III clinical trial delivery including medical monitoring, data management, project management, biostatistics, quality assurance, medical writing, regulatory affairs, clinical trial sites, recruitment, and clinical PK/PD services for pharma and biotech sponsors.
  • Drug Development Consulting Strategic and scientific consultancy covering regulatory affairs, CMC consulting, non-clinical development, due diligence, biosample project management, statistics and study design, clinical PK/PD and translational modelling, medical writing, and clinical trials legal services for drug development sponsors and investors.
  • Human Challenge Trials Specialist controlled-pathogen challenge trials in dedicated quarantine facilities using proprietary models for RSV, Influenza, COVID-19, HRV, hMPV, Malaria, and Asthma & COPD, including virus production and characterization, participant screening and recruitment, and clinical delivery to generate early efficacy data.
  • Laboratory Solutions Advanced laboratory services across bioanalysis and characterization, virology, immunology, molecular biology, microbiology, PBMC processing, assay development and validation, preclinical PK/PD studies, and Bio-Rad Droplet Digital PCR for clinical trial sponsors.
  • Biobank and Storage Solutions HTA-licensed cryostorage and biobanking services with multi-temperature storage, 24/7 monitoring, full chain-of-custody management, and fast local access for biotech, pharma, and research partners' biological samples and clinical materials.
  • Integrated Solutions End-to-end integrated drug development platform combining clinical, laboratory, recruitment, and consultancy expertise, including the Speed to Clinic Accelerator, Investor Readiness Consulting, Integrated Clinical Trial Delivery, Translational Research Consulting, and EU Expansion Strategy for sponsors.

Quantifiable outcome

  • 1,900+ trials completed successfully
  • +2 more outcomes

Companies that use Venn Life Sciences

Customer profile

Segments5 records

Ideal customer profiles5 records

Venn Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Venn Life Sciences partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • CRS (Clinical Research Services)coreStrategic or Co-development Partner · 1 January 2025German clinical research company acquired by hVIVO in January 2025. CRS operates clinical research facilities in Germany and is now integrated under the unified One hVIVO brand, extending capabilities in early-phase clinical trials and recruitment.
  • CryostorecoreStrategic or Co-development PartnerSpecialist cryostorage and biobanking company acquired by hVIVO. Provides HTA-licensed cryostorage and biobanking services with multi-temperature storage, 24/7 monitoring, and full chain-of-custody management. Now part of the integrated One hVIVO brand.
  • Bio-Rad LaboratoriescoreTechnology or IntegrationhVIVO became the first in Europe to deploy Bio-Rads Droplet Digital PCR technology, enhancing bioanalysis and characterization capabilities for clinical trials and laboratory services.
  • Venn Life SciencescoreStrategic or Co-development PartnerAcquired company now operating under the unified One hVIVO brand. Part of the strategic integration bringing together hVIVO, Cryostore, CRS, and Venn Life Sciences to offer fully integrated early-phase drug development solutions.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Venn Life Sciences competitors and assessment

Company assessment

Direct peers

  • Pharmaron: Integrated CRO/CDMO offering lab services, preclinical research, clinical trial support and drug development consulting. Comparable to hVIVO's integrated early-phase platform with comparable sponsor base and similar emphasis on accelerating biotech drug development.
  • Medpace: Mid-sized global CRO focused on Phase I-IV clinical development with strong medical, regulatory and biostatistics expertise. Closely comparable operating model to hVIVO in serving small-to-mid biotech with full-service early-phase trials, though without the specialized human challenge franchise.
  • Worldwide Clinical Trials: Mid-sized global CRO with Phase I-IV capabilities across complex therapeutic areas. Comparable in size and sponsor mix to hVIVO, particularly for biotech and specialty pharma early-phase work.

Broad incumbents

  • ICON plc: One of the world's largest clinical CROs offering Phase I-IV trial delivery, lab services and consulting. Significantly larger and more diversified than hVIVO, but directly competes for the same global pharma and biotech sponsors seeking integrated early-phase and Phase II/III delivery.
  • IQVIA: Global mega-CRO with clinical operations, real-world data, laboratory and consulting services. Comparable to hVIVO in serving pharma/biotech sponsors with integrated drug development solutions, but at vastly greater scale and geographic reach.
  • Charles River Laboratories: Preclinical and clinical CRO with strong biologics and laboratory services franchises. Comparable to hVIVO in combining preclinical/early-phase research capabilities with safety and bioanalytical lab services for pharma and biotech sponsors.
  • Parexel International: Global full-service CRO with Phase I-IV capabilities, biostatistics, regulatory affairs and bioanalytical services. Competes with hVIVO for pharma and biotech early-phase contracts but with materially greater global infrastructure.
  • Syneos Health: Global biopharma solutions organization combining clinical CRO services with commercial capabilities. Competes with hVIVO for full-service Phase I-III trials and consultancy work from pharma and biotech sponsors.
  • SGS Health & Nutrition: Diversified testing, inspection and certification company with a life sciences/CRO division including early-phase clinical and bioanalytical services. Comparable to hVIVO's lab and clinical research capabilities, particularly in infectious disease and vaccine studies, though SGS operates across many non-pharma verticals.
  • Eurofins Scientific: Global laboratory services group with a significant clinical trial laboratory and central lab business. Comparable to hVIVO in providing bioanalytical, virology, immunology and biomarker lab services to pharma and biotech sponsors, though without equivalent clinical operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Venn Life Sciences social profiles

Digital presence

Venn Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Venn Life Sciences leadership team

Management profile

Number of profiles

Profiles4 records

Venn Life Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Venn Life Sciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Venn Life Sciences M&A and investment

M&A and investment

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Venn Life Sciences

What does Venn Life Sciences do?

Venn Life Sciences provides contract clinical research services from pre-clinical through Phase III, delivering full-service CRO capabilities including clinical trial management, regulatory affairs, biostatistics, medical monitoring, and data management. The company also offers drug development consulting (CMC, regulatory, non-clinical, due diligence, PK/PD), specialized human challenge trials for infectious disease, bioanalytical and virology laboratory services, and HTA-licensed cryostorage and biobanking. Services are delivered to pharmaceutical, biotechnology, and CRO customers across the UK and Germany under the integrated One hVIVO brand.

Is Venn Life Sciences a public or private company?

Venn Life Sciences is a public company. It is classified as corporate owned and is currently operating.

When was Venn Life Sciences founded?

Venn Life Sciences was founded in 1989. It employs 51 to 100 people.

Where is Venn Life Sciences based?

Venn Life Sciences is headquartered in Whitechapel, United Kingdom, in the Europe region.

How does Venn Life Sciences make money?

Five revenue lines are on record. Clinical Trial Services are the primary driver. The others are drug Development Consulting, laboratory Services, human Challenge Trials and biobank and Storage Solutions.

Who are Venn Life Sciences's main competitors?

Direct peers on record are Pharmaron, Medpace and Worldwide Clinical Trials. Broad incumbents are ICON plc, IQVIA, Charles River Laboratories, Parexel International, Syneos Health, SGS Health & Nutrition and Eurofins Scientific.

Does Venn Life Sciences have an API?

No public API is recorded for Venn Life Sciences.

What industry is Venn Life Sciences in?

Venn Life Sciences's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals